rs146582474
Variant summary
Our verdict is Pathogenic. Variant got 22 ACMG points: 22P and 0B. PVS1PM2PP3_StrongPP5_Very_Strong
The NM_003982.4(SLC7A7):c.895-2A>T variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000183 in 1,609,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/2 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003982.4 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 22 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC7A7 | NM_003982.4 | c.895-2A>T | splice_acceptor_variant | ENST00000674313.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC7A7 | ENST00000674313.1 | c.895-2A>T | splice_acceptor_variant | NM_003982.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000342 AC: 52AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000426 AC: 107AN: 251284Hom.: 0 AF XY: 0.000339 AC XY: 46AN XY: 135866
GnomAD4 exome AF: 0.000166 AC: 242AN: 1456852Hom.: 0 Cov.: 30 AF XY: 0.000152 AC XY: 110AN XY: 725062
GnomAD4 genome ? AF: 0.000341 AC: 52AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74490
ClinVar
Submissions by phenotype
Lysinuric protein intolerance Pathogenic:6Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Nov 10, 2023 | This sequence change affects an acceptor splice site in intron 6 of the SLC7A7 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs146582474, gnomAD 0.5%), and has an allele count higher than expected for a pathogenic variant. Disruption of this splice site has been observed in individuals with lysinuric protein intolerance (PMID: 10080182, 10080183). It is commonly reported in individuals of Finnish ancestry (PMID: 10080182, 10080183). ClinVar contains an entry for this variant (Variation ID: 816701). Studies have shown that disruption of this splice site results in 10 base pair deletion and introduces a premature termination codon (PMID: 10080182, 10080183). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 30, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 07, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 19, 2021 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2008 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at